These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1586175)

  • 1. Turnover of exogenous artificial surfactant.
    Ashton MR; Postle AD; Hall MA; Austin NC; Smith DE; Normand IC
    Arch Dis Child; 1992 Apr; 67(4 Spec No):383-7. PubMed ID: 1586175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylcholine composition of endotracheal tube aspirates of neonates and subsequent respiratory disease.
    Ashton MR; Postle AD; Hall MA; Smith SL; Kelly FJ; Normand IC
    Arch Dis Child; 1992 Apr; 67(4 Spec No):378-82. PubMed ID: 1586174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of exogenous surfactant to phospholipase A2 degradation.
    Duncan JE; Hatch GM; Belik J
    Can J Physiol Pharmacol; 1996 Aug; 74(8):957-63. PubMed ID: 8960386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant.
    Hamdan AH; Shaw NJ
    Pediatr Pulmonol; 1998 Mar; 25(3):191-5. PubMed ID: 9556011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial phospholipid analysis in preterm infants: comparison of Exosurf and Survanta.
    Lloyd J; Todd DA; John E
    Early Hum Dev; 1999 Mar; 54(2):157-68. PubMed ID: 10213294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Dechant KL; Faulds D
    Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant.
    Corbet AJ; Long WA; Murphy DJ; Garcia-Prats JA; Lombardy LR; Wold DE
    J Paediatr Child Health; 1991 Aug; 27(4):245-9. PubMed ID: 1958425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant.
    Lancet; 1992 Dec; 340(8832):1363-9. PubMed ID: 1360087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant phosphatidylcholine composition during dexamethasone treatment in chronic lung disease.
    Ashton MR; Postle AD; Smith DE; Hall MA
    Arch Dis Child Fetal Neonatal Ed; 1994 Sep; 71(2):F114-7. PubMed ID: 7979464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
    Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
    J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
    Corbet A; Gerdes J; Long W; Avila E; Puri A; Rosenberg A; Edwards K; Cook L
    J Pediatr; 1995 Jun; 126(6):969-78. PubMed ID: 7776110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in pulmonary artery pressure in infants with respiratory distress syndrome following treatment with Exosurf.
    Hamdan AH; Shaw NJ
    Arch Dis Child Fetal Neonatal Ed; 1995 May; 72(3):F176-9. PubMed ID: 7796233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy.
    Rubin BK; Ramirez O; King M
    Chest; 1992 Apr; 101(4):1080-5. PubMed ID: 1555424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
    Online J Curr Clin Trials; 1992 Nov; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group. Canadian Exosurf Neonatal Follow-Up Group.
    Casiro O; Bingham W; MacMurray B; Whitfield M; Saigal S; Vincer M; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S53-60. PubMed ID: 7745512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a protein-free, synthetic surfactant on survival and pulmonary function in preterm lambs.
    Durand DJ; Clyman RI; Heymann MA; Clements JA; Mauray F; Kitterman J; Ballard P
    J Pediatr; 1985 Nov; 107(5):775-80. PubMed ID: 3840530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
    Wach R; Darlow B; Bourchier D; Broadbent R; Knight D; Selby R
    N Z Med J; 1994 Jun; 107(980):234-7. PubMed ID: 8208494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the changes in the a/A oxygen ratio after administration of two surfactants for the treatment of neonatal respiratory distress syndrome.
    Bassiouny MR; Remo C; Cherian E
    J Trop Pediatr; 1997 Feb; 43(1):38-41. PubMed ID: 9078827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.